These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2979676)

  • 1. The effect of a long-acting somatostatin analogue (SMS 201-995) on intermediary metabolism and gut hormones after a test meal in normal subjects.
    Fuessl HS; Burrin JM; Williams G; Adrian TE; Bloom SR
    Aliment Pharmacol Ther; 1987 Aug; 1(4):321-30. PubMed ID: 2979676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long acting somatostatin-analogue, SMS 201 995, on gut hormone secretion in normal subjects.
    Kraenzlin ME; Wood SM; Neufeld M; Adrian TE; Bloom SR
    Experientia; 1985 Jun; 41(6):738-40. PubMed ID: 2861106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial effects of SMS 201-995 on gut hormones and glucose tolerance.
    Williams G; Fuessl H; Kraenzlin M; Bloom SR
    Scand J Gastroenterol Suppl; 1986; 119():73-83. PubMed ID: 2876509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA; Bock A; Keller U
    Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
    Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
    Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans.
    Creutzfeldt W; Lembcke B; Fölsch UR; Schleser S; Koop I
    Am J Med; 1987 May; 82(5B):49-54. PubMed ID: 2884879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged inhibition of meal-stimulated acid secretion and gastrin release following single subcutaneous administration of octreotide (SMS 201-995) in man.
    Karnes WE; Maxwell V; Sytnik B; Chew P; Walsh JH
    Aliment Pharmacol Ther; 1989 Dec; 3(6):527-38. PubMed ID: 2518866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man.
    Møller N; Petrany G; Cassidy D; Sheldon WL; Johnston DG; Laker MF
    Clin Sci (Lond); 1988 Oct; 75(4):345-50. PubMed ID: 3058374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitus.
    Grossman LD; Shumak SL; George SR; Singer W; Zinman B
    J Clin Endocrinol Metab; 1989 Jan; 68(1):63-7. PubMed ID: 2642488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.
    Scheen AJ; Gillet J; Rosenthaler J; Guiot J; Henrivaux P; Jandrain B; Lefèbvre PJ
    Diabetologia; 1989 Nov; 32(11):801-9. PubMed ID: 2687064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
    Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I
    Digestion; 1987; 36(2):108-24. PubMed ID: 2883060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man.
    Barnes AJ; Long RG; Adrian TE; Vale W; Brown MR; Rivier JE; Hanley J; Ghatei MA; Sarson DL; Bloom SR
    Clin Sci (Lond); 1981 Nov; 61(5):653-6. PubMed ID: 6116553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly.
    Plewe G; Beyer J; Krause U; Neufeld M; del Pozo E
    Lancet; 1984 Oct; 2(8406):782-4. PubMed ID: 6148524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.
    Misumi A; Shiratori K; Lee KY; Barkin JS; Chey WY
    Surgery; 1988 Apr; 103(4):450-5. PubMed ID: 2895501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man.
    Owens DR; Jones MK; Birtwell AJ; Burge CT; Jones IR; Heyburn PJ; Hayes TM; Heding LG
    Horm Metab Res; 1984 Dec; 16 Suppl 1():195-9. PubMed ID: 6152435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subcutaneous injection of a long-acting analogue of somatostatin (SMS 201-995) on plasma thyroid-stimulating hormone in normal human subjects.
    Itoh S; Tanaka K; Kumagae M; Takeda F; Morio K; Kogure M; Hasegawa M; Horiuchi T; Watabe T; Miyabe S
    Life Sci; 1988; 42(26):2691-9. PubMed ID: 2898717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic effects of dopamine in man.
    Pernet A; Hammond VA; Blesa-Malpica G; Burrin J; Orskov H; Alberti KG; Johnston DG
    Eur J Clin Pharmacol; 1984; 26(1):23-8. PubMed ID: 6143668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of SMS 201-995 on meal and CCK-stimulated peptide YY release.
    Kuvshinoff BW; Rudnicki M; McFadden DW
    J Surg Res; 1991 May; 50(5):425-9. PubMed ID: 2038180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.